Abstract
The Etest was evaluated as a possible alternative to the standard agar dilution method for susceptibility testing of nine antimicrobial agents against Flavobacterium species. In studies of 100 clinical isolates, the agreement between the MICs (+/-1 log2 dilution) obtained by the two methods was acceptable for cefotaxime, ceftazidime, amikacin, minocycline, ofloxacin, and ciprofloxacin (> 90%). Conversely, the agreement between the results obtained for piperacillin was limited (84%). The overall agreement was 92.5%.
Full Text
The Full Text of this article is available as a PDF (57.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aber R. C., Wennersten C., Moellering R. C., Jr Antimicrobial susceptibility of flavobacteria. Antimicrob Agents Chemother. 1978 Sep;14(3):483–487. doi: 10.1128/aac.14.3.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Altmann G., Bogokovsky B. In-vitro sensitivity of Elavobacterium meningosepticum to antimicrobial agents. J Med Microbiol. 1971 May;4(2):296–299. doi: 10.1099/00222615-4-2-296. [DOI] [PubMed] [Google Scholar]
- Baker C. N., Stocker S. A., Culver D. H., Thornsberry C. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J Clin Microbiol. 1991 Mar;29(3):533–538. doi: 10.1128/jcm.29.3.533-538.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown D. F., Brown L. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J Antimicrob Chemother. 1991 Feb;27(2):185–190. doi: 10.1093/jac/27.2.185. [DOI] [PubMed] [Google Scholar]
- Brown D. F. The E-Test challenged with selected strains. Diagn Microbiol Infect Dis. 1992 Jul;15(5):465–468. doi: 10.1016/0732-8893(92)90091-7. [DOI] [PubMed] [Google Scholar]
- Fass R. J., Barnishan J. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis. 1980 Nov-Dec;2(6):841–853. doi: 10.1093/clinids/2.6.841. [DOI] [PubMed] [Google Scholar]
- Hsueh P. R., Hsiue T. R., Hsieh W. C. Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. Clin Infect Dis. 1996 May;22(5):858–860. doi: 10.1093/clinids/22.5.858. [DOI] [PubMed] [Google Scholar]
- Hsueh P. R., Hsiue T. R., Wu J. J., Teng L. J., Ho S. W., Hsieh W. C., Luh K. T. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis. 1996 Sep;23(3):550–555. doi: 10.1093/clinids/23.3.550. [DOI] [PubMed] [Google Scholar]
- Hsueh P. R., Teng L. J., Ho S. W., Hsieh W. C., Luh K. T. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol. 1996 Aug;34(8):1908–1913. doi: 10.1128/jcm.34.8.1908-1913.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hsueh P. R., Wu J. J., Hsiue T. R., Hsieh W. C. Bacteremic necrotizing fasciitis due to Flavobacterium odoratum. Clin Infect Dis. 1995 Nov;21(5):1337–1338. doi: 10.1093/clinids/21.5.1337. [DOI] [PubMed] [Google Scholar]
- Huang M. B., Baker C. N., Banerjee S., Tenover F. C. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J Clin Microbiol. 1992 Dec;30(12):3243–3248. doi: 10.1128/jcm.30.12.3243-3248.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ratner H. Flavobacterium meningosepticum. Infect Control. 1984 May;5(5):237–239. [PubMed] [Google Scholar]
- Sanchez M. L., Barrett M. S., Jones R. N. The E-Test applied to susceptibility tests of gonococci, multiply-resistant enterococci, and Enterobacteriaceae producing potent beta-lactamases. Diagn Microbiol Infect Dis. 1992 Jul;15(5):459–463. doi: 10.1016/0732-8893(92)90090-g. [DOI] [PubMed] [Google Scholar]
- Scully B. E., Neu H. C. Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa. J Antimicrob Chemother. 1986 Nov;18 (Suppl 500):179–185. doi: 10.1093/jac/18.supplement_d.179. [DOI] [PubMed] [Google Scholar]
- Sheridan R. L., Ryan C. M., Pasternack M. S., Weber J. M., Tompkins R. G. Flavobacterial sepsis in massively burned pediatric patients. Clin Infect Dis. 1993 Aug;17(2):185–187. [PubMed] [Google Scholar]
- Siegman-Igra Y., Schwartz D., Soferman G., Konforti N. Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections. Med Microbiol Immunol. 1987;176(2):103–111. doi: 10.1007/BF00200682. [DOI] [PubMed] [Google Scholar]
- Strandberg D. A., Jorgensen J. H., Drutz D. J. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob Agents Chemother. 1983 Aug;24(2):282–286. doi: 10.1128/aac.24.2.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tam A. Y., Yung R. W., Fu K. H. Fatal pneumonia caused by Flavobacterium meningosepticum. Pediatr Infect Dis J. 1989 Apr;8(4):252–254. [PubMed] [Google Scholar]